Have a feature idea you'd love to see implemented?
Let us know!
NTRA Natera Inc
Price (delayed)
$122.35
Market cap
$15.13B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.45
Enterprise value
$14.76B
Naterais a pioneer and global leader in cell-free DNA testing from a simple blood draw. The mission of the company is to change the management of disease worldwide with a
Highlights
Natera's gross profit has surged by 85% YoY and by 21% QoQ
The EPS has increased by 49% YoY and by 21% from the previous quarter
Key stats
What are the main financial stats of NTRA
Market
Valuations
Earnings
Shares outstanding
123.68M
Market cap
$15.13B
Enterprise value
$14.76B
Price to earnings (P/E)
N/A
Price to book (P/B)
17.96
Price to sales (P/S)
11.05
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
10.85
Revenue
$1.36B
EBIT
-$277.76M
EBITDA
-$234.61M
Free cash flow
-$107.32M
Per share
Balance sheet
Liquidity
EPS
-$2.45
Free cash flow per share
-$0.87
Book value per share
$6.81
Revenue per share
$11.07
TBVPS
$12.35
Total assets
$1.52B
Total liabilities
$680.47M
Debt
$425.22M
Equity
$836.52M
Working capital
$987.24M
Debt to equity
0.51
Current ratio
4.14
Quick ratio
3.89
Net debt/EBITDA
1.58
Margins
Efficiency
Dividend
EBITDA margin
-17.2%
Gross margin
53.8%
Net margin
-21.5%
Operating margin
-23.1%
Return on assets
-19.9%
Return on equity
-36.7%
Return on invested capital
-32.2%
Return on capital employed
-23.1%
Return on sales
-20.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
NTRA stock price
How has the Natera stock price performed over time
Intraday
-3.49%
1 week
-2.7%
1 month
-3.82%
1 year
187.88%
YTD
95.32%
QTD
-3.62%
Financial performance
How have Natera's revenue and profit performed over time
Revenue
$1.36B
Gross profit
$732.63M
Operating income
-$313.73M
Net income
-$292.12M
Gross margin
53.8%
Net margin
-21.5%
Natera's gross profit has surged by 85% YoY and by 21% QoQ
The company's net margin has surged by 61% YoY and by 29% QoQ
NTRA's operating margin has surged by 58% year-on-year and by 27% since the previous quarter
NTRA's revenue is up by 46% year-on-year and by 13% since the previous quarter
Growth
What is Natera's growth rate over time
Valuation
What is Natera stock price valuation
P/E
N/A
P/B
17.96
P/S
11.05
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
10.85
The EPS has increased by 49% YoY and by 21% from the previous quarter
The stock's P/B is 56% more than its last 4 quarters average of 11.5 and 41% more than its 5-year quarterly average of 12.7
NTRA's equity is up by 40% year-on-year and by 5% since the previous quarter
NTRA's revenue is up by 46% year-on-year and by 13% since the previous quarter
NTRA's price to sales (P/S) is 44% higher than its last 4 quarters average of 7.7 and 5% higher than its 5-year quarterly average of 10.5
Efficiency
How efficient is Natera business performance
The ROS has soared by 62% YoY and by 30% from the previous quarter
The ROE has soared by 59% YoY and by 26% from the previous quarter
The ROA has soared by 52% year-on-year and by 24% since the previous quarter
The return on invested capital has increased by 32% year-on-year and by 17% since the previous quarter
Dividends
What is NTRA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for NTRA.
Financial health
How did Natera financials performed over time
NTRA's total assets is 123% higher than its total liabilities
NTRA's total assets is up by 22% YoY and by 3.3% QoQ
The current ratio is up by 8% year-on-year
The company's debt is 49% lower than its equity
NTRA's equity is up by 40% year-on-year and by 5% since the previous quarter
The debt to equity has contracted by 30% YoY and by 6% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.